Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
/
mega-study
Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody